StockNews.com upgraded shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) from a buy rating to a strong-buy rating in a report issued on Wednesday.
A number of other brokerages have also weighed in on TCMD. Oppenheimer lowered Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th. BTIG Research cut Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research note on Tuesday, November 5th. Finally, B. Riley began coverage on Tactile Systems Technology in a research note on Thursday, September 26th. They issued a “buy” rating and a $23.00 price target on the stock.
View Our Latest Stock Analysis on Tactile Systems Technology
Tactile Systems Technology Stock Performance
Hedge Funds Weigh In On Tactile Systems Technology
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Arcadia Investment Management Corp MI purchased a new stake in shares of Tactile Systems Technology in the 3rd quarter worth approximately $29,000. Gladius Capital Management LP bought a new stake in Tactile Systems Technology in the third quarter worth $44,000. Quarry LP purchased a new stake in shares of Tactile Systems Technology in the second quarter worth $46,000. Magnetar Financial LLC purchased a new position in shares of Tactile Systems Technology in the 2nd quarter worth about $130,000. Finally, SG Americas Securities LLC bought a new position in Tactile Systems Technology in the 3rd quarter worth about $156,000. Institutional investors own 83.43% of the company’s stock.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Read More
- Five stocks we like better than Tactile Systems Technology
- How Can Investors Benefit From After-Hours Trading
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
- The How And Why of Investing in Oil Stocks
- Discover 2 Under-the-Radar Aerospace Stocks Set for 2025 Growth
- How to Start Investing in Real Estate
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.